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Background: As illustrated by the Montreal classification, gastroesophageal reflux disease (GERD) is much more
than heartburn and patients constitute a heterogeneous group. Understanding if links exist between patients’
characteristics and GERD symptoms, and classify subjects based on symptom-profile could help to better understand,
diagnose, and treat GERD. The aim of this study was to identify distinct classes of GERD patients according to symptom
profiles, using a specific statistical tool: Latent class analysis.
Methods: An observational single-visit study was conducted in 5 European countries in 7700 adults with typical
symptoms. A latent class analysis was performed to identify “latent classes” and was applied to 12 indicator
symptoms.
Results: On 7434 subjects with non-missing indicators, latent class analysis yielded 5 latent classes. Class 1 grouped the
highest severity of typical GERD symptoms during day and night, more digestive and non-digestive GERD symptoms, and
bad sleep quality. Class 3 represented less frequent and less severe digestive and non-digestive GERD symptoms, and
better sleep quality than in class 1. In class 2, only typical GERD symptoms at night occurred. Classes 4 and 5 represented
daytime and nighttime regurgitation. In class 4, heartburn was also identified and more atypical digestive symptoms.
Multinomial logistic regression showed that country, age, sex, smoking, alcohol use, low-fat diet, waist circumference,
recent weight gain (>5 kg), elevated triglycerides, metabolic syndrome, and medical GERD treatment had a significant
effect on latent classes.
Conclusion: Latent class analysis classified GERD patients based on symptom profiles which related to patients’
characteristics. Although further studies considering these proposed classes have to be conducted to determine
the reproducibility of this classification, this new tool might contribute in better management and follow-up of
patients with GERD.
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Gastroesophageal reflux disease (GERD) refers to reflux
of the gastric content into the esophagus, leading to
esophagitis, reflux symptoms impairing the quality of
life, or long-term complications [1].
GERD is one of the most common disorders seen by
primary care providers and gastroenterologists in the
United States as well as in Europe [2]. Besides the mil-
lions of medical visits to physicians and the billions of
dollars in annual costs [3], frequent or severe GERD
symptoms are associated with time lost from work [4],
impaired health-related quality of life [5], and esophageal
adenocarcinoma [6], further emphasizing the clinical sig-
nificance of this entity.
Although heartburn is highly specific to characterize
GERD, patients usually report a number of associated
symptoms such as regurgitation, nausea, sore throat,
cough, eructation, globus, hiccups, chest pain, sleep dis-
turbances, etc [7,8]. Consequently, individuals with the
typical GERD symptoms of heartburn and acid regurgi-
tation constitute a heterogeneous group. The combina-
tions of the different symptoms, their associations, but
also their link with clinical or demographic factors (age,
body mass index [BMI], history of GERD, comorbidities,
etc.), might be more prominent in certain groups of
patients. An improvement in the understanding of the
structure underlying these individual differences in
GERD symptoms would help to individualize subject
profiles and to adapt GERD management.
The difficulty is to find tools organizing the many
symptoms and identify groups of patients suffering
from a specific combination of symptoms. A statistical
method that could help making such distinctions is the
latent class analysis (LCA). LCA can best be thought of
as an “improved” cluster analysis, which uses statistical
(rather than mathematical) methodology to construct
the results. It is based on the statistical concept of like-
lihood. Parameters are estimated for class profiles (the
description of each class) and the size of each class. A
difference is that cases are not absolutely assigned to
classes, but have a probability of membership for each
class. It can deal with all types of data – binary, con-
tinuous and count data. So, first of all, the aim of a
LCA is to reduce the complexity of the data by identi-
fying clusters of observed variables, the latent classes,
and then, to reduce the heterogeneity of the population
of patients by identifying sub populations based on the
probability of each of the subjects to belong to a
certain latent class. Compared with cluster analysis
applied to ordinal or continuous variables, a LCA can
also be performed to categorize people on dichotom-
ous variables and can quantify the extent to which in-
dicators are not perfectly related to class membership
(i.e., measurement error) [9]. The resulting latent classrepresents the groups of homogeneous individuals
within the class to which they belong. These groups
are then heterogeneous across the different classes.
Recently, the LCA has been used in various health
conditions to examine subgroups in weight loss strat-
egies used among women [9], parenting characteristics
associated with children’s BMI [10], obesity risk [11],
and maternal pregnancy weight status associated with
Attention Deficit/Hyperactivity Disorder in their off-
spring [12]. The results of these different studies have
shown that the LCA is an effective and valid method to
categorize individuals with similar characteristics.
The purpose of this study was to try to identify distinct
classes of adult subjects with respect to their different
GERD symptoms by means of a LCA, and to investigate




This international, multicenter, non-interventional, ob-
servational study was conducted in France, Greece,
Italy, Russia, and Spain. A total of 7917 adult subjects
suffering from GERD and presenting at least one typ-
ical GERD symptom (i.e., heartburn and/or regurgita-
tion), at least once a week, in the week prior to the first
(and only) study visit, were enrolled in the study. As
this was a non-interventional study, neither changes to
the current treatment that the subject received, were
required, nor was additional treatment provided by the
Sponsor.
This study was conducted in accordance with the eth-
ical principles that have their origin in the Declaration of
Helsinki and was consistent with the applicable regulatory
requirements. Local ethics committee approval was ob-
tained where required (see Additional file 1 – Study
approvals), and all participants provided written in-
formed consent (except for France where it was not
required for this type of data collection).
Participants
Participants were men or women consulting their gen-
eral practitioner or a specialist, at least 18 years old, who
had an established diagnosis of GERD according to the
investigator, or an occurrence of at least one typical
GERD symptom (i.e., heartburn or regurgitation), at least
once a week in the last 3 months, and presented at least
1 of the typical GERD symptoms (i.e., heartburn or
regurgitation) in the week preceding the study visit.
Subjects who exclusively presented atypical digestive
or non-digestive symptoms (e.g., epigastralgia, respira-
tory disturbances, thoracic manifestations, etc.), had a
current or recent (less than 1 year) history of gastric or
duodenal ulcer, a history of surgery of the upper
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tract or ears-nose-throat (ENT) system were not se-
lected. The study was performed by specialty sites
(gastroenterologists, endoscopists, and internal medicine
specialists) in all participating countries, except for France,
where it was performed by general practitioners.
All subjects documented in this study continued to re-
ceive treatment as required, according to usual care in
their treatment setting and at the discretion of the treat-
ing physician.Assessments
At the single visit, the subject’s characteristics of the par-
ticipants were recorded (demographic data, medical his-
tory) as well as all available data about comorbidities
(diabetes, metabolic syndrome, cardiovascular diseases,
osteoarthropathic treatments, irritable bowel syndrome,
sleep apnea, and anti-reflux and bariatric surgery), con-
comitant medication, smoking, drinking, and other lifestyle
habits, as well as if the main purpose of the participant’s
visit was GERD.
Weight, height, and waist circumference (using a tape
measure) were measured, and BMI was calculated. The
investigator also asked if the subject remembered his/
her weight from 12 and 24 months ago, and the weight
change in the last 12 months was recorded.
The typical GERD symptoms (heartburn and regurgi-
tation), present in the week before the first (and only)
study visit, were recorded in detail by means of specific
multiple-choice questions regarding time (daytime and/
or nighttime), severity and frequency of occurrence, and
the overall evolution of GERD symptoms in the last
12 months. Atypical digestive (nausea, eructation, slow
digestion/early satiety, epigastralgia) and non-digestive
(thoracic manifestations i.e., atypical precordial pain,
respiratory disturbances i.e., cough, and ENT symptoms
i.e., hoarseness, pharyngeal pain, globus, etc.) GERD
symptoms, present in the week before the study visit,
were also documented as well as “warning signs”, such
as dysphagia, weight loss, anemia, anorexia, gastrointes-
tinal bleeding, asthenia, and vomiting. As nighttime
GERD can cause sleep disorders and thus affect quality
of life, each subject was asked to evaluate his/her quality
of sleep and to report the presence of sleep disturbances
(early awakening, difficulty falling asleep, nocturnal
awakening, nightmares) in the week before the study
visit.
Finally, the investigator documented the subject’s
GERD history (first diagnosis of GERD as well as the oc-
currence of a previous endoscopy), GERD management
(including data about GERD non-medical and medical
treatment), as well as recommendations for future GERD
consultations (if any).The latent class analysis was performed on 13 indicator
variables (i.e., daytime heartburn, daytime regurgitation,
nighttime heartburn and/or nighttime regurgitation, nau-
sea/eructation, slow digestion/early satiety, epigastralgia,
dysphagia/vomiting, digestive bleeding/anemia, thoracic
manifestations, respiratory disturbances, ENT symp-
toms, early awakening/difficulty falling asleep, nocturnal




The “per-protocol” set of subjects was defined as all sub-
jects who met all inclusion/exclusion criteria. The primary
analysis (i.e., latent class analysis, LCA), was performed on
all subjects from the per-protocol analysis set with non-
missing indicator variables.
Latent class analysis
The classification of subjects was carried out by per-
forming a LCA [13-16] on 13 binomial (present/absent)
indicator variables representing 13 indicator symptoms.
Multiple LCA models were explored with the number of
classes set to 2, 3, 4, 5, 6, 7, 8, 9, 10, and 11. The optimal
number of classes came from the model with the best
model fit.
The descriptive analysis of nominal/ordinal data com-
prised tabulation of frequency and percentages. The de-
scriptive analysis of continuous data comprised the mean,
standard deviation, median, extreme values, and 95% confi-
dence interval. Statistical comparisons between groups, if
appropriate, were performed using the Fisher’s exact test
(nominal data) and the Wilcoxon two-sample test (ordinal/
continuous data). Multinomial logistic regression modeling
was used to explore the relation between the classification
and associated factors.
All analyses were performed using Statistical Analysis
Software (SAS version 9.1), except for the LCA, which
was performed with Mplus (version 6.11).
Sample size determination
In this type of exploratory study with the chosen method
of analysis, a large sample was typically required in order
to adequately investigate the objectives. Based on the
large number of variables of interest and the availability
of resources, the sample size was planned to be 8200.
The possible number of symptom profiles was equal to
8192 (2 power 13). If the sample size was equal to or lar-
ger than 8192, theoretically, each symptom profile could
possibly be represented at least once. Such a sample size
would avoid obtaining a sparsely populated multivariate
contingency table, thereby reducing the validity of the
likelihood ratio statistics for setting the number of latent
classes.
Table 1 Number of subjects for each indicator variable
(primary efficacy set N = 7434)
n (%)
S1: daytime heartburn 6319 (85.0)
S2: daytime regurgitation 5217 (70.2)
S3: nighttime heartburn and/or
nighttime regurgitation
4540 (61.1)
S4: nausea, eructation 3852 (51.8)
S5: slow digestion, early satiety 2758 (37.1)
S6: epigastralgia 3154 (42.4)
S7: dysphagia, vomiting 1169 (15.7)
S8: digestive bleeding, anemia* 124 (1.7)
S9: thoracic manifestations (atypical precordial pain) 1125 (15.1)
S10: respiratory disturbances (cough) 1522 (20.5)
S11: ENT symptoms (hoarseness, pharyngeal pain,
globus, etc.)
1783 (24.0)
S12: early awakening, difficulty falling asleep 2003 (26.9)
S13: nocturnal awakening, nightmares 2799 (37.7)
n = number of subjects with observations.
ENT = ears, nose, throat.
*Indicator variable S8 (digestive bleeding, anemia) was not included in the latent
class analysis.
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Participants
Overall, 7917 subjects, enrolled in five countries (France,
Greece, Italy, Russia, and Spain), participated in this
single-visit observational study. The per-protocol popu-
lation consisted of 7700 subjects and the primary ana-
lysis was performed on 7434 subjects. The subject’s
overall characteristics can be found in Additional file 2.
Although the primary analysis set was less than the cal-
culated sample size, the representativeness of the effect-
ive sample was not affected, because the sample size was
based on the theoretically possible number of unique
symptom profiles and the included subjects presented
approximately 1400 different profiles.
Latent class analysis
LCA is a statistical method to identify unobserved sub-
groups of related cases (latent classes) from a set of
observed categorical variables. For this study the cat-
egorical data that were used were 13 typical GERD
symptoms. The LCA model parameters were the preva-
lence of each of the latent classes and conditional re-
sponse probabilities such as, the probability for each
patient of being member of each class and for each of
the categorical variables the probability for each latent
class. Parameters were estimated by the maximum likeli-
hood criterion. The LCA was performed on 7434 sub-
jects (only the ones with non-missing indicator variables
were included). Of the 7434 subjects included in the pri-
mary analysis set, 124 had a positive score on indicator
variable S8 (digestive bleeding/anemia). Because this
indicator variable showed a very low probability (<0.1)
in all classes in all LCA models that were investigated,
it was decided to exclude this indicator variable from
the analysis and to re-run the LCA on 12 indicator
variables.
A stepwise approach was used to determine the
optimum number of classes meaning that the LCA was
run multiple times with the number of classes set to 2,
3, 4, 5, 6, 7, 8, 9, 10 and 11. The Bayesian information
criterion (BIC), the Lo-Mendell-Rubin test, the Akaike
information criterion (AIC) and the likelihood ratio chi-
square were used to assess the number of latent classes.
These statistical parameters did not unequivocally yield
one optimal number of classes but indicated solutions of
5, 6 or 7 classes. Therefore, clinicians involved in the
protocol scientific committee were asked which classifi-
cation (5, 6 or 7 classes) was the most conform to clin-
ical experience.
At the end, the 5-class classification was preferred be-
cause it yielded clinically well recognizable class-profiles
and the interpretation of a 5-class classification was
easier than classifications with more classes. Each of these 5
latent classes had its own characteristic probability profilefor the 12 indicator symptoms. Table 1 shows the number
of subjects with GERD indicator symptoms that were used
in the LCA.
Probability profile for the 12 GERD indicator symptoms
The indicator symptom probability profile for each of
the 5 classes is presented in Figure 1.
Each class of subjects was described using typical and
atypical GERD symptoms, digestive and non-digestive
symptoms, warning signs, and sleep disturbances.
Class 1 (N = 1598, 21.5%) represented subjects with a
very high probability of daytime heartburn and regurgi-
tation, and a high probability of nighttime heartburn
and/or regurgitation. The probability of all other symp-
toms was higher than in any of the other classes.
Class 2 (N = 845, 11.4%) was characterized by the ab-
sence of heartburn and regurgitation during the day and
presence of the typical symptoms during the night.
Nighttime problems were also reflected by a medium
probability of nocturnal awakenings and nightmares.
Class 3 (N = 2375, 31.9%) also showed a high probabil-
ity of daytime as well as nighttime heartburn and regurgita-
tion. A medium probability was seen for atypical
digestive symptoms (S4-S6) and for sleep disorders.
Class 3 differed from class 1 in the low probability of
non-digestive symptoms (S9-S11).
Class 4 (N = 1181, 15.9%) was the third class with a
very high probability of daytime heartburn and regurgi-
tation, however, the probability of nighttime heartburn
or regurgitation was low. The probability of the other
Figure 1 Probability profile for a positive score on the indicator symptoms for each of the 5 latent classes (primary analysis set N = 7434). S8 is
not presented in the Figure because, due to its very low probability, it was not included in the final LCA. On the X-axis the probability is reported.
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nal awakening and nightmares. The low probability of
these latter symptoms corresponded to the absence of
the nighttime core symptoms.
Class 5 (N = 1435, 19.3%) was different from the other
classes because in this class there was only one symptom
with a high probability: daytime heartburn. Daytime re-
gurgitation had a medium probability and the probability




















Figure 2 Country distribution per class (primary analysis
set N = 7434).Comparison among the 5 latent classes
The relative distribution of the 5 classes per country is
shown in Figure 2.
More than 45% of the Russian subjects were found in
class 5 and very few of them in class 2. For the other
countries, less than 20% of subjects were in class 2.
There were less French subjects in classes 4 and 5, than
in classes 1, 2, and 3.
The gender distribution was equal in all classes except
for class 1 where 57% were females.
BMI did not differ between classes. Number of over-
weight/obese subjects varied from 56% in class 4 to 64% in
class 1 (Figure 3). Based on the subject’s history data, the
highest occurrences of medical history or concurrent
comorbidities were found in class 1 (see Additional file 2).The frequency table of the typical GERD symptoms
for each class is presented in Table 2 while the atypical
digestive as well as non-digestive GERD symptoms are
described in Table 3. Warning signs were mostly applic-
able for the subjects in class 1 (46.2%) and dysphagia
was the most commonly reported warning sign (29.6%
of the subjects in class 1).
In classes 1, 2, and 3, most subjects (85.1, 73.5, and
70.7%, respectively) had sleep disorders; hence, they con-
sidered their quality of sleep mainly as bad or very




















Figure 3 BMI distribution per class (primary analysis
set N = 7434).
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quently in class 1.Relation between the classification in the 5 latent classes
and subject- and GERD-related factors
The relation between the classification in 5 latent classes
and subject- and GERD-related factors was explored
using multinomial logistic regression modeling. The LCA
classes were considered as dependent binomial variables
without any ordering of the latent classes.Table 2 Typical GERD symptoms in the 5 classes (primary effi
n (%)
Class 1 Class 2
N = 1598 N = 845
Heartburn
None 53 (3.3) 41 (4.9)
Mild 325 (20.3) 310 (36.7)
Moderate 913 (57.1) 423 (50.1)
Severe 307 (19.2) 71 (8.4)
Regurgitation
None 107 (6.7) 157 (18.6)
Mild 543 (34.0) 356 (42.1)
Moderate 757 (47.4) 273 (32.3)
Severe 191 (12.0) 59 (7.0)
Number of days per week
1 day per week 70 (4.4) 171 (20.2)
2 to 3 days per week 529 (33.1) 407 (48.2)
4 to 5 days per week 546 (34.2) 171 (20.2)
6 to 7 days per week 453 (28.3) 96 (11.4)
Time of occurrence
Only during the day 405 (25.3) 0
Only during the night 1 (0.1) 845 (100)
Both during day and night 1192 (74.6) 0
N = number of subjects.
n = number of subjects with observations.In total 24 different factors were examined. Of the fac-
tors that were found highly correlated, the one with the
strongest effect was kept in the final model. The follow-
ing 11 factors were entered into this final model:
– The factor with the strongest effect was country.
– For the factors gender, smoking, and alcohol use,
a difference was seen between class 1 and the other
classes. Class 1 was the only class where females
(57%) and males (43%) were not equally represented.
Class 1 represented the highest percentage of
smoking subjects (31%), which varied from 22 to
28% in the other classes. Alcohol use was also
highest in class 1 (42%), this varied from 36 to
38% in the other classes.
– Although weight and BMI did not show an effect in
the model, the factors recent weight loss and weight
gain >5 kg did. The number of subjects with recent
weight loss was highest in class 1 (34%) and lowest
in class 5 (24%). Weight gain >5 kg occurred less
frequently and varied from 4 to 6% (classes 1 and 5).
Waist circumference was also highest in class 1 but
the differences were small.
– A low fat diet was adopted by 58% of the subjects in
classes 4 and 5. In the other classes this varied from
46 to 54% (classes 2 and 1, respectively).cacy set N = 7434)
Class 3 Class 4 Class 5
N = 2375 N = 1181 N = 1435
12 (0.5) 204 (17.3) 0
599 (25.2) 369 (31.2) 684 (47.7)
1439 (60.6) 544 (46.1) 681 (47.5)
325 (13.7) 64 (5.4) 70 (4.9)
199 (8.4) 2 (0.2) 1063 (74.1)
989 (41.6) 650 (55.0) 225 (15.7)
1031 (43.4) 465 (39.4) 130 (9.1)
156 (6.6) 64 (5.4) 17 (1.2)
131 (5.5) 159 (13.5) 258 (18.0)
823 (34.7) 523 (44.3) 631 (44.0)
804 (33.9) 279 (23.6) 309 (21.5)
617 (26.0) 220 (18.6) 237 (16.5)
189 (8.0) 1094 (92.6) 1206 (84.0)
0 0 0
2186 (92.0) 87 (7.4) 229 (16.0)
Table 3 Occurrence of atypical GERD Symptoms in the 5 classes (primary efficacy set N = 7434)
Class 1 Class 2 Class 3 Class 4 Class 5
n (%) N = 1598 N = 845 N = 2375 N = 1181 N = 1435
Digestive GERD symptoms
Reported any atypical digestive symptom* 1536 (96.1) 656 (77.6) 1972 (83.0) 1097 (92.9) 652 (45.4)
Slow digestion/early satiety 880 (55.1) 285 (33.7) 874 (36.8) 516 (43.7) 203 (14.1)
Other digestive symptoms 197 (12.3) 75 (8.9) 208 (8.8) 114 (9.7) 169 (11.8)
Epigastralgia 1004 (62.8) 326 (38.6) 1045 (44.0) 474 (40.1) 305 (21.3)
Eructation 1037 (64.9) 331 (39.2) 1042 (43.9) 566 (47.9) 147 (10.2)
Nausea 508 (31.8) 125 (14.8) 410 (17.3) 217 (18.4) 125 (8.7)
Non-Digestive GERD symptoms
Thoracic manifestations1 643 (40.3) 127 (15.0) 168 (7.1) 116 (9.8) 71 (5.0)
Pulmonary symptoms2 971 (60.8) 216 (25.6) 138 (5.8) 74 (6.3) 123 (8.6)
ENT symptoms3 1181 (73.9) 227 (26.9) 40 (1.7) 168 (14.2) 167 (11.7)
N = number of subjects.
n = number of subjects with observations.
ENT = ears, nose, throat.
*Subjects could report more than one atypical digestive symptom.
1Atypical precordial pain.
2Cough, etc.
3Hoarseness, pharyngeal pain, globus, etc.
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subjects of class 1 and varied from 11% in class 5
to 15% in class 2. Highest percentage of elevated
triglycerides was in seen class 3 (66%); in class 1
this was 63%, and the lowest in class 5 (54%)
– Medical GERD treatment was most reported in
classes 1 (69%) and 2 (68%), and fewest in classes 4
and 5 (both 62%).
Discussion
Using a LCA based on 12 indicator variables, represent-
ing typical and atypical symptoms of GERD, warning
signs, and sleep disturbances, 5 symptom profile classes
were identified in 7434 European GERD patients. Be-
cause no statistical tool allows to determine the optimal
number of classes that mirror real life, the final decision

















Figure 4 Quality of sleep per class (primary analysis set
N = 7434).6 or 7 classes) was taken according to an expert-
investigators’consensus. This consensus was based, on
one side, on clinical experience and practice and, on the
other side, on practical considerations as using a rela-
tively low number of classes (i.e. 5 classes) when a rela-
tively limited number of indicators (i.e. 12 indicators)
are evaluated. Our opinion is that this approach will in-
crease the probability for clinicians to appropriate them-
selves such a classification; of course, the relevance of
the classification in 5 classes should be prospectively
tested in usual care conditions.
Class 1 (very high probability of daytime regurgitation
and heartburn; high probability of nighttime typical
symptoms and all other symptoms as well) comprised
patients where the typical GERD symptoms had the
highest severity. Patients also had more digestive as well
as non-digestive GERD symptoms and their sleep quality
was worse than in the other classes. This class grouped
patients with the worst symptoms overall. In this class,
almost half of the patients in PPI therapy took them
continuously. Class 3 (high probability of daytime and
nighttime heartburn and regurgitation; low probability
of non-digestive symptoms) was quite comparable to
class 1 with patients with a high probability and severity
of typical symptoms, occurring during the day as well as
the night. As in class 1, almost half of the patients who
took PPIs, took them continuously. However, the digest-
ive GERD symptoms and the sleep disturbances oc-
curred less and were less severe than in class 1. The
main difference between class 1 and 3 was the probabil-
ity of non–digestive symptoms that was low in class 3.
Class 2 (very high probability of nighttime typical
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fered from the other classes, mainly in the fact that pa-
tients only suffered from typical symptoms during the
night. Although a comparable PPI treatment modality
was observed (i.e., almost half of the PPI users took this
treatment continuously), heartburn and regurgitation
were less severe than in class 1 and 3. Classes 4 and 5
(high probability of daytime heartburn; low probability
of nighttime heartburn and/or regurgitation) showed a
quite similar patients’ profile, except for daytime regurgi-
tation that was present with high probability only in
class 4. The frequency of typical GERD symptoms was
lower than in classes 1 and 3 and a little higher than in
class 2. The severity of heartburn was lower in classes 4
and 5 than in the other classes but still moderate/severe
for half of the subjects. Class 5 (only a high probability
of daytime heartburn) differed from class 4 mainly in the
severity of regurgitation: moderate to severe for only ap-
proximately 10% of the subjects compared to almost
45% in class 4. Also the occurrence of atypical digestive
symptoms was higher in class 4. PPI use was somewhat
lower in class 5 than in class 4, but with the same treat-
ment modality (i.e., continuous treatment) of the other
classes.
In our study, minor differences among the 5 classes
were seen in demographic data (i.e., the percentage of
overweight/obese subjects was highest in class 1, but the
differences were small), while the factor with the stron-
gest effect on patients’ distribution was the country. In
Russia 47% of the subjects was found in class 5, mainly
suffering from daytime heartburn as the only symptom
with a high probability. Class 1 represented the subjects
with the highest probability of all symptoms; there were
twice as much French, Greek, and Italian subjects in this
class than Spanish and Russian. Class 3, with less digest-
ive and non-digestive symptoms than in class 1, was
most represented in the Spanish population. These re-
sults illustrate the likely country-specific expression of
symptoms for the same disease. Additional studies are
requested to determine whether these differences are
linked to relative pathophysiological differences or only
to cultural characteristics in expressing symptoms.
Although the applicability and relevance of these 5
classes have now to be established in clinical practice,
this approach may be of interest in GERD. In fact, reflux
symptoms are common, especially in primary care, but
definition and classification of GERD remain uneasy due
to its wide spectrum of clinical manifestations. Most pa-
tients with GERD do not have erosive disease, are la-
beled as having NERD, but they can experience GERD
symptoms just as severely as do patients with endoscop-
ically confirmed mucosal damages [17]. For this reason,
symptom evaluation is a crucial aspect both in the
diagnosis of GERD (i.e., when objective tests asendoscopy and oesophageal pH evaluations are relatively
insensitive) and in the evaluation of the effectiveness of
therapy, when a diagnosis of GERD has been already
established. Heartburn and acid regurgitation have long
been considered as the cardinal symptoms of GERD and
have been necessary inclusion criteria in most thera-
peutic trials. But the clinical manifestations of GERD are
now appreciated to be broad-based, including many
atypical and extra-esophageal symptoms such as non-
cardiac chest pain and asthma as well as a wide array of
associated symptoms such as nausea, lower gastrointes-
tinal complaints, and sleep disturbances that contribute
to the marked reduction in quality of life for GERD pa-
tients. So, to address patient needs, the full range of
GERD symptoms should be taken into account [17,18].
Another element to be considered is that symptoms in
addition to/other than heartburn may respond differ-
ently to therapy. There are post hoc analyses of studies
in endoscopy negative GERD patients which show that
reflux symptoms respond less well to PPI therapy in pa-
tients who have more non-heartburn symptoms or
where heartburn is not dominant. Similarly, regurgita-
tion may not respond as well to therapy as heartburn.
Moreover, patients are less likely to respond to initial re-
flux therapy if they have concomitant symptoms of irrit-
able bowel syndrome and if they are labeled as having
NERD [18]. In addition to this, a minority of GERD pa-
tients have multiple unexplained symptoms which may
be associated with other psychological distress [18].
Recently, the experts who met in Montreal have pro-
posed a symptom subclassification into esophageal and
extra-esophageal symptoms [8]. Other investigational
teams performed studies to evaluate patients’ symptom
profiles in GERD disease. Ponce et al [19]. analyzed the
symptom profile of patients with typical GERD manifes-
tations (heartburn and/or regurgitation), comparing un-
treated patients with those with persistent symptoms
despite treatment. A total of 2356 Spanish patients were
included in a prospective, observational, cross-sectional
study under conditions of standard clinical practice.
Dyspeptic symptoms were about 90% in both groups
and supra-esophageal ones were also common (50-60%).
People with persistent symptoms despite treatment were
older, had more supra-esophageal symptoms and the
typical and dyspeptic symptoms were more severe in
these patients. Older age resulted in a risk factor for
supra-esophageal symptoms, female gender for dyspeptic
symptoms, and BMI for greater severity of GERD symp-
toms. In Turkey, Bor et al [20]. performed a study to de-
termine the prevalence and clinical spectrum of GERD
in a low-income region. Using a reflux questionnaire val-
idated by Locke et al. at Mayo Clinic, they included 630
randomly selected, low-income participants older than
20 years, living in a population of 8857 Caucasian adults.
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similar in low-income populations to that in developed
countries, but with a different symptom profile (i.e., a
lower incidence of heartburn and a higher incidence of
regurgitation and dyspepsia). A comparison between the
frequent and the occasional symptom group (i.e., sub-
jects with either of the typical symptoms less than once
a week) revealed that only two of the other symptoms,
namely dysphagia and odynophagia, were significantly
higher in the frequent symptom group. They also found
that the prevalence of heartburn symptoms, but not re-
gurgitation, increased significantly with age and that
heartburn and regurgitation were both significantly more
common in women. In conclusion, both these studies
found that dyspeptic symptoms as well as typical and
atypical symptoms should all be considered in relation
to GERD because they are associated in nearly 50% of pa-
tients. Although clinical practice guidelines were closely
followed, it seemed that the diagnostic procedures were not
always adequate to determine clear different symptom
profiles. Thus, our study is an additional attempt to define
relevant subgroups in GERD patients, using the LCA.
The LCA applied to eating behavior and physical ac-
tivity have also provided useful results in determining
subtypes of children using multiple dimensions of obes-
ity risks [11] and interesting results have also been re-
ported in weight loss strategies among women [9],
parenting characteristics associated with children’s BMI
[10], and maternal pregnancy weight associated with atten-
tion deficit hyperactivity disorder in their offspring [12].
The results of our LCA have shown that a person-
centered analytical approach could be an effective
method to determine a classification of adults suffering
from typical GERD symptoms and to describe the most
frequent symptom profiles and characteristics. Among
patients complaining from at least one of the major
symptoms of GERD, i.e. heartburn or regurgitation, sub-
groups exist. This is an important point to be considered
for patients’ management in the clinical practice. Indeed,
besides heartburn and regurgitation, other symptoms
often exist and have to be taken into account in order to
provide to the patient an overall and satisfactory symp-
toms relief. We can speculate that patients'expectations
are not the same between, for instance, Class 5 patients
suffering only from daytime heartburn and patients from
Class 2 or 3 with also nocturnal typical symptoms, a
medium probability of atypical symptoms and sleep dis-
orders. Of course, from a clinical perspective, the rele-
vance of this classification should be prospectively tested
in further interventional studies and/or in real world set-
ting. These findings may call for refinement of GERD
programs, as to our knowledge, this is one of the first at-
tempts in GERD research to estimate latent classes of
symptom profiles and characteristics. As this study onlycomprised one visit, symptom changes over time have
not been investigated. Patients could switch classes
throughout time due to changes in e.g., therapy, lifestyle
habits. However, incorporating these different classes
into GERD diagnosis could help in determining a spe-
cific patient profile and a specific treatment approach.
Conclusion
In conclusion, our study has shown, for the first time,
the potential interest of using a LCA in determining sub-
groups of patients with GERD. Further studies considering
these proposed classes have now to be conducted to deter-
mine the reproducibility of this classification and its contri-
bution in the patient management and follow-up.
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